Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00005815 · COMPLETED

Trial details

NCT number: NCT00005815
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Intraocular Melanoma Melanoma (Skin)

Start date: 1999-12-01
Primary completion: 2004-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.